Systemic Autoinflammatory Diseases—Clinical Rheumatic Challenges Series 3
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 62
Special Issue Editor
Interests: autoinflammation; adult onset Still’s disease; biomarkers; inflammasome; proteasome；rheumatology; rheumatoid arthritis; biologic drugs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoinflammation is an important new field for clinical and experimental rheumatology. In fact, it has renewed and intensified the interaction and exchange of knowledge between experts as well as practitioners for pediatric and adult diseases. Not only has the number of described entities and affected patients gradually increased, but associated organ manifestations and complications have also been characterized in more detail. Based on the underlying mechanisms, target therapies nowadays include cytokine inhibitors for IL-1ß, IL-6, interferon-, and TNF-alpha. In the near future, we expect to improve management further by using novel or improved international classification criteria as well as established outcome measures. This will facilitate novel approaches and clinical trials. Several already active international registers will provide us with long-term data for efficacy and safety.
The Special Issue entitled “Systemic Autoinflammatory Diseases—Clinical Rheumatic Challenges Series 3” of the Journal of Clinical Medicine is now open for submissions. This Special Issue welcomes all types of papers on the broad spectrum of the clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, as rheumatology is increasingly linked to immunology.
Prof. Dr. Eugen Feist
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoinflammation
- inflammasome
- inflammasomopathies
- interferonopathies
- relopathies
- proteasome-associated syndromes
- syndrome of undifferentiated recurrent fever
- pro-inflammatory cytokines
- biomarkers.
